Astria Therapeutics
ATXS
ATXS
30 hedge funds and large institutions have $28.1M invested in Astria Therapeutics in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding
Funds holding: 24 → 30 (+6)
1.23% more ownership
Funds ownership: 0.45% → 1.68% (+1.2%)
Holders
30
Holding in Top 10
3
Calls
$959K
Puts
–
Top Buyers
| 1 | +$10M | |
| 2 | +$2.57M | |
| 3 | +$2.3M | |
| 4 |
AC
Armistice Capital
New York
|
+$1.92M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.86M |
Top Sellers
| 1 | -$113K | |
| 2 | -$66.6K | |
| 3 | -$39.8K | |
| 4 |
Bank of New York Mellon
New York
|
-$25K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$22K |